References
Reference articles
1. Watts DM, Ksiasek TG, Linthicum KJ, et al. Crimean-Congo hemorrhagic fever. In: Monath TP, ed. The arboviruses: epidemiology and ecology. Boca Raton: CRC; 1988.
2. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol. 1979;15:307-417. Abstract
3. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203-14. Abstract
4. Sahak MN, Arifi F, Saeedzai SA. Descriptive epidemiology of Crimean-Congo hemorrhagic fever (CCHF) in Afghanistan: reported cases to National Surveillance System, 2016-2018. Int J Infect Dis. 2019 Nov;88:135-40.Full text Abstract
5. Butenko AM, Karganova G. Crimean Congo hemorrhagic fever in Russia and other countries of the former Soviet Union. In: Ergonul O, Whitehouse CA, eds. Crimean Congo hemorrhagic fever: a global perspective. Dordrecht: Springer; 2007:99-115.
6. Woodall JP. Personal reflections. In: Ergonul O, Whitehouse CA, eds. Crimean Congo hemorrhagic fever: a global perspective. Dordrecht: Springer; 2007:23-32.
7. Athar MN, Baqai HZ, Ahmad M, et al. Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002. Am J Trop Med Hyg. 2003;69:284-7.Full text Abstract
8. Mardani M, Jahromi MK, Naieni KH, et al. The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin Infect Dis. 2003;36:1613-8.Full text Abstract
9. Al-Abri SS, Abaidani IA, Fazlalipour M, et al. Current status of Crimean-Congo haemorrhagic fever in the World Health Organization Eastern Mediterranean Region: issues, challenges, and future directions. Int J Infect Dis. 2017 May;58:82-9.Full text Abstract
10. Nabeth P, Thior M, Faye O, et al. Human Crimean-Congo hemorrhagic fever, Senegal. Emerg Infect Dis. 2004;10:1881-2.Full text Abstract
11. Papa A, Bino S, Llagami A, et al. Crimean-Congo hemorrhagic fever in Albania, 2001. Eur J Clin Microbiol Infect Dis. 2002;21:603-6. Abstract
12. Drosten C, Minnak D, Emmerich P, et al. Crimean-Congo hemorrhagic fever in Kosovo. J Clin Microbiol. 2002;40:1122-3.Full text Abstract
13. Papa A, Christova I, Papadimitriou E, et al. Crimean-Congo hemorrhagic fever in Bulgaria. Emerg Infect Dis. 2004;10:1465-7.Full text Abstract
14. Ergonul O, Celikbaş A, Dokuzoguz B, et al. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004;39:284-7.Full text Abstract
15. Maltezou HC, Papa A, Tsiodras S, et al. Crimean-Congo hemorrhagic fever in Greece: a public health perspective. Int J Infect Dis. 2009;13:713-6.Full text Abstract
16. Dunster L, Dunster M, Ofula V, et al. First documentation of human Crimean-Congo hemorrhagic fever, Kenya. Emerg Infect Dis. 2002;8:1005-6.Full text Abstract
17. Nabeth P, Cheikh DO, Lo B, et al. Crimean-Congo hemorrhagic fever, Mauritania. Emerg Infect Dis. 2004;10:2143-9.Full text Abstract
18. Knust B, Medetov ZB, Kyraubayev KB, et al. Crimean-Congo hemorrhagic fever, Kazakhstan, 2009-2010. Emerg Infect Dis. 2012;18:643-5.Full text Abstract
19. Tishkova FH, Belobrova EA, Valikhodzhaeva M, et al. Crimean-Congo hemorrhagic fever in Tajikistan. Vector Borne Zoonotic Dis. 2012;12:722-6.Full text Abstract
20. Patel AK, Patel KK, Mehta M, et al. First Crimean-Congo hemorrhagic fever outbreak in India. J Assoc Physicians India. 2011;59:585-9. Abstract
21. Mishra AC, Mehta M, Mourya DT, et al. Crimean-Congo haemorrhagic fever in India. Lancet. 2011;378:372. Abstract
22. Negredo A, de la Calle-Prieto F, Palencia-Herrejón E, et al. Autochthonous Crimean-Congo hemorrhagic fever in Spain. N Engl J Med. 2017 Jul 13;377(2):154-61. Abstract
23. García Rada A. First outbreak of Crimean-Congo haemorrhagic fever in western Europe kills one man in Spain. BMJ. 2016;354:i4891. Abstract
24. World Health Organization. Government of Uganda confirms outbreak of Crimean-Congo hemorrhagic and Rift Valley fevers. January 2018 [internet publication].Full text
25. World Health Organization. Weekly Epidemiological Monitor. Crimean-Congo hemorrhagic fever in Afghanistan. December 2017 [internet publication].Full text
26. World Health Organization. Weekly Epidemiological Monitor. Crimean-Congo hemorrhagic fever in Afghanistan:Year 2020. Jan 2021 [internet publication].Full text
27. UK Health Security Agency. Case of Crimean-Congo haemorrhagic fever identified in England. Apr 2022 [internet publication].Full text
28. World Health Organization. Disease outbreak news. Crimean-Congo Hemorrhagic Fever - Iraq. June 2022 [internet publication].Full text
29. Yilmaz GR, Buzgan T, Irmak H, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis. 2009;13:380-6.Full text Abstract
30. Ergonul O, Whitehouse CA. Introduction. In: Ergonul O, Whitehouse CA, eds. Crimean Congo hemorrhagic fever: a global perspective. Dordrecht: Springer; 2007:3-11.
31. Nasirian H. New aspects about Crimean-Congo hemorrhagic fever (CCHF) cases and associated fatality trends: A global systematic review and meta-analysis. Comp Immunol Microbiol Infect Dis. 2020 Apr;69:101429.Full text Abstract
32. Shepherd AJ, Swanepoel R, Leman PA, et al. Field and laboratory investigation of Crimean-Congo haemorrhagic fever virus (Nairovirus, family Bunyaviridae) infection in birds. Trans R Soc Trop Med Hyg. 1987;81:1004-7. Abstract
33. Belobo JTE, Kenmoe S, Kengne-Nde C, et al. Worldwide epidemiology of Crimean-Congo Hemorrhagic Fever Virus in humans, ticks and other animal species, a systematic review and meta-analysis. PLoS Negl Trop Dis. 2021 Apr;15(4):e0009299.Full text Abstract
34. Leblebicioglu H, Eroglu C, Erciyas-Yavuz K, et al. Role of migratory birds in spreading Crimean-Congo hemorrhagic fever, Turkey. Emerg Infect Dis. 2014;20:1331-4.Full text Abstract
35. England ME, Phipps P, Medlock JM, et al. Hyalomma ticks on northward migrating birds in southern Spain: implications for the risk of entry of Crimean-Congo haemorrhagic fever virus to Great Britain. J Vector Ecol. 2016;41:128-34.Full text Abstract
36. Public Health England. HAIRS risk assessment: Crimean-Congo haemorrhagic fever. May 2021 [internet publication].Full text
37. Gargili A, Midilli K, Ergonul O, et al. Crimean-Congo hemorrhagic fever in European part of Turkey: genetic analysis of the virus strains from ticks and a seroepidemiological study in humans. Vector Borne Zoonotic Dis. 2011;11:747-52. Abstract
38. Aradaib IE, Erickson BR, Karsany MS, et al. Multiple Crimean-Congo hemorrhagic fever virus strains are associated with disease outbreaks in Sudan, 2008-2009. PLoS Negl Trop Dis. 2011;5:e1159.Full text Abstract
39. Meric Koc M, Willke A. A case of Crimean-Congo hemorrhagic fever with long incubation period in Kocaeli, Turkey. Mikrobiyol Bul. 2012;46:129-33. Abstract
40. Ergonul O. Crimean-Congo hemorrhagic fever. In: Ergonul O, Can F, Akova M, Madoff L, eds. Emerging infectious diseases: clinical case studies. London: Academic Press; 2014:136-49.
41. Akıncı E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2013;13:429-37. Abstract
42. Peters CJ, Zaki SR. Role of the endothelium in viral hemorrhagic fevers. Crit Care Med. 2002;30(suppl 5):S268-73. Abstract
43. Geisbert TW, Jahrling PB. Exotic emerging viral diseases: progress and challenges. Nat Med. 2004;10(suppl 12):S110-21. Abstract
44. Chen JP, Cosgriff TM. Hemorrhagic fever virus-induced changes in hemostasis and vascular biology. Blood Coagul Fibrinolysis. 2000;11:461-83. Abstract
45. Ergonul O, Tuncbilek S, Baykam N, et al. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006;193:941-4.Full text Abstract
46. Bray M. Comparative pathogenesis of Crimean Congo hemorrhagic fever and Ebola hemorrhagic fever. In: Ergonul O, Whitehouse CA, eds. Crimean Congo hemorrhagic fever: a global perspective. Dordrecht: Springer; 2007:221-31.
47. Rodrigues R, Paranhos-Baccalà G, Vernet G, et al. Crimean-Congo hemorrhagic fever virus-infected hepatocytes induce ER-stress and apoptosis crosstalk. PLoS One. 2012;7:e29712.Full text Abstract
48. Saksida A, Duh D, Wraber B, et al. Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin Vaccine Immunol. 2010;17:1086-93.Full text Abstract
49. Duh D, Saksida A, Petrovec M, et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis. 2007;13:1769-72.Full text Abstract
50. Cevik MA, Erbay A, Bodur H, et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis. 2007;45:e96-100.Full text Abstract
51. World Health Organization. Crimean-Congo haemorrhagic fever. January 2013 [internet publication].Full text
52. Centers for Disease Control and Prevention. Factsheet: Crimean-Congo hemorrhagic fever (CCHF) [internet publication].Full text
53. Leblebicioglu H, Sunbul M, Memish ZA, et al. Consensus report: preventive measures for Crimean-Congo hemorrhagic fever during Eid-al-Adha festival. Int J Infect Dis. 2015;38:9-15.Full text Abstract
54. Pshenichnaya NY, Sydenko IS, Klinovaya EP, et al. Possible sexual transmission of Crimean-Congo hemorrhagic fever. Int J Infect Dis. 2016;45:109-111.Full text Abstract
55. Ergonul O, Battal I. Potential sexual transmission of Crimean-Congo hemorrhagic fever infection. Jpn J Infect Dis. 2014;67:137-138.Full text Abstract
56. Töpfer-Petersen E, Schill WB. A new separation method of subcellular fractions of boar spermatozoa. Andrologia. 1981 Mar-Apr;13(2):174-6.Full text Abstract
57. Hawman DW, Ahlén G, Appelberg KS, et al. A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model. Nat Microbiol. 2021 Feb;6(2):187-195.Full text Abstract
58. Berber E, Çanakoğlu N, Tonbak Ş, et al. Development of a protective inactivated vaccine against Crimean-Congo hemorrhagic fever infection. Heliyon. 2021 Oct;7(10):e08161.Full text Abstract
59. Centers for Disease Control and Prevention. Yellow Book: health information for international travel. Chapter 3: mosquitoes, ticks & other arthropods. Jul 2019 [internet publication].Full text
60. Centers for Disease Control and Prevention. Crimean-Congo haemorrhagic fever (CCHF). Sep 2013 [internet publication].Full text
61. Tarantola A, Ergonul O, Tattevin P. Estimates and prevention of Crimean Congo hemorrhagic fever risks for health care workers. In: Ergonul O, Whitehouse CA, eds. Crimean Congo hemorrhagic fever: a global perspective. Dordrecht: Springer; 2007:281-94.
62. Ergonul O, Zeller H, Celikbas A, et al. The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region. Int J Infect Dis. 2007;11:48-51.Full text Abstract
63. Tezer H, Sucakli IA, Sayli TR, et al. Crimean-Congo hemorrhagic fever in children. J Clin Virol. 2010;48:184-186. Abstract
64. European Centre for Disease Prevention and Control. Meeting report: consultation on Crimean-Congo haemorragic fever prevention and control. September 2008 [internet publication].Full text
65. Centers for Disease Control and Prevention. Viral hemorrhagic fever (VHF) 2011 case definition [internet publication].Full text
66. Drosten C, Kümmerer BM, Schmitz H, et al. Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res. 2003;57:61-87. Abstract
67. Drosten C, Göttig S, Schilling S, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol. 2002;40:2323-30.Full text Abstract
68. Atkinson B, Chamberlain J, Logue CH, et al. Development of a real-time RT-PCR assay for the detection of Crimean-Congo hemorrhagic fever virus. Vector Borne Zoonotic Dis. 2012;12:786-93.Full text Abstract
69. Bartolini B, Gruber CE, Koopmans M, et al. Laboratory management of Crimean-Congo haemorrhagic fever virus infections: perspectives from two European networks. Euro Surveill. 2019 Jan;24(5):1800093.Full text Abstract
70. Ergonul O, Celikbas A, Baykam N, et al. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006;12:551-4.Full text Abstract
71. Burt FJ, Swanepoel R, Braack LE. Enzyme-linked immunosorbent assays for the detection of antibody to Crimean-Congo haemorrhagic fever virus in the sera of livestock and wild vertebrates. Epidemiol Infect. 1993;111:547-57.Full text Abstract
72. Zeller H. Laboratory diagnosis of Crimean Congo hemorrhagic fever. In: Ergonul O, Whitehouse CA, eds. Crimean Congo hemorrhagic fever: a global perspective. Dordrecht: Springer; 2007:233-43.
73. Rathore SS, Manju AH, Wen Q, et al. Crimean-Congo haemorrhagic fever-induced liver injury: A systematic review and meta-analysis. Int J Clin Pract. 2021 Nov;75(11):e14775.Full text Abstract
74. Qaderi S, Hatami H, Omid AM, et al. Vaginal bleeding as a sign of Crimean-Congo hemorrhagic fever infection: a case report. J Med Case Rep. 2022 Feb 22;16(1):76.Full text Abstract
75. Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect. 2011;17:494-501.Full text Abstract
76. Hensley LE, Wahl-Jensen V, McCormick JB, et al. Viral hemorrhagic fevers. In: Cohen J, Powderly W, Opal S, eds. Infectious diseases. 3rd ed. Maryland Heights, MO: Mosby; 2010:1231-1237.
77. Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet. 2008;371:1861-1871. Abstract
78. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007;49:13-21.Full text Abstract
79. Dokuzoguz B, Celikbas AK, Gök ŞE, et al. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis. 2013;57:1270-4.Full text Abstract
80. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res. 2008;78:125-31. Abstract
81. World Health Organization. Clinical management of patients with viral haemorrhagic fever: a pocket guide for the front-line health worker. February 2016 [internet publication].Full text
82. Leblebicioglu H, Bodur H, Dokuzoguz B, et al. Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2012;12:805-11. Abstract
83. McCormick JB, King IJ, Webb PA, et al. Lassa fever: effective therapy with ribavirin. N Engl J Med. 1986;314:20-6. Abstract
84. Ergonul O. Treatment of Crimean Congo hemorrhagic fever. In: Ergonul O, Whitehouse CA, eds. Crimean Congo hemorrhagic fever: a global perspective. Dordrecht: Springer; 2007:245-60.
85. Bausch DG, Hadi CM, Khan SH, et al. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis. 2010;51:1435-41.Full text Abstract
86. Watts DM, Ussery MA, Nash D, et al. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am J Trop Med Hyg. 1989;41:581-5. Abstract
87. Tignor GH, Hanham CA. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res. 1993;22:309-25. Abstract
88. Paragas J, Whitehouse CA, Endy TP, et al. A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. Antiviral Res. 2004;62:21-5. Abstract
89. Tasdelen Fisgin N, Ergonul O, Doganci L, et al. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur J Clin Microbiol Infect Dis. 2009;28:929-33. Abstract
90. Ozbey SB. Impact of early ribavirin use on fatality of CCHF. Klimik J. 2010;23:6-10.
91. Izadi S, Salehi M. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study. Jpn J Infect Dis. 2009;62:11-5. Abstract
92. Ozbey SB, Kader Ç, Erbay A, et al. Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2014;14:300-2. Abstract
93. Koksal I, Yilmaz G, Aksoy F, et al. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol. 2010;47:65-8. Abstract
94. Elaldi N, Bodur H, Ascioglu S, et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect. 2009;58:238-44. Abstract
95. Ascioglu S, Leblebicioglu H, Vahaboglu H, et al. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother. 2011;66:1215-22.Full text Abstract
96. Johnson S, Henschke N, Maayan N, et al. Ribavirin for treating Crimean Congo haemorrhagic fever. Cochrane Database Syst Rev. 2018 Jun 5;6:CD012713.Full text Abstract
97. Leblebicioglu H, Sunbul M, Guner R, et al. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study. Clin Microbiol Infect. 2016;22:387.Full text Abstract
98. Ergönül Ö, Keske Ş, Çeldir MG, et al. Systematic review and meta-analysis of postexposure prophylaxis for Crimean-Congo hemorrhagic fever virus among healthcare workers. Emerg Infect Dis. 2018 Sep;24(9):1642-8.Full text Abstract
99. Celikbas AK, Dokuzoğuz B, Baykam N, et al. Crimean-Congo hemorrhagic fever among health care workers, Turkey. Emerg Infect Dis. 2014;20:477-9.Full text Abstract
100. Guner R, Hasanoglu I, Tasyaran MA, et al. Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever? Vector Borne Zoonotic Dis. 2014;14:601-5. Abstract
101. Vassilenko SM, Vassilev TL, Bozadjiev LG, et al. Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever. Lancet. 1990;335:791-2. Abstract
102. Dimitrov DS. Antibodies to CCHFV for prophylaxis and treatment. In: Ergonul O, Whitehouse CA, eds. Crimean Congo hemorrhagic fever: a global perspective. Dordrecht: Springer; 2007:261-9.
103. Kubar A, Haciomeroglu M, Ozkul A, et al. Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR. Jpn J Infect Dis. 2011;64:439-43. Abstract
104. Jabbari A, Besharat S, Abbasi A, et al. Crimean-Congo hemorrhagic fever: case series from a medical center in Golestan province, Northeast of Iran (2004). Indian J Med Sci. 2006 Aug;60(8):327-9.Full text Abstract
105. Fabara SP, Ortiz JF, Smith DW, et al. Crimean-Congo Hemorrhagic Fever Beyond Ribavirin: A Systematic Review. Cureus. 2021 Sep;13(9):e17842.Full text Abstract
106. Oestereich L, Rieger T, Neumann M, et al. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS Negl Trop Dis. 2014;8:e2804.Full text Abstract
107. Hawman DW, Haddock E, Meade-White K, et al. Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques. Antiviral Res. 2020 Sep;181:104858. Abstract
108. Belobo JTE, Kenmoe S, Kengne-Nde C, et al. Worldwide epidemiology of Crimean-Congo Hemorrhagic Fever Virus in humans, ticks and other animal species, a systematic review and meta-analysis. PLoS Negl Trop Dis. 2021 Apr;15(4):e0009299.Full text Abstract
109. Wada H, Thachil J, Di Nisio M, et al. Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost. 2013;4:761-7.Full text Abstract
Use of this content is subject to our disclaimer